Caffeine, creatine, GRIN2A and Parkinson's disease progression
David K. Simon*, Cai Wu, Barbara C. Tilley, Katja Lohmann, Christine Klein, Haydeh Payami, Anne Marie Wills, Michael J. Aminoff, Jacquelyn Bainbridge, Richard Dewey, Robert A. Hauser, Susen Schaake, Jay S. Schneider, Saloni Sharma, Carlos Singer, Caroline M. Tanner, Daniel Truong, Peng Wei, Pei Shieen Wong, Tianzhong Yang
*Korrespondierende/r Autor/-in für diese Arbeit
- Department of Neurology
- Harvard University
- Baylor College of Medicine
- Department of Neurology
- University of Alabama
- Center for Genomic Medicine
- HudsonAlpha Institute for Biotechnology
- Department of Neurology
- University of California, San Francisco
- University of Colorado Anschutz Medical Campus
- University of Texas Southwestern
- University of South Florida Tampa
- University of Pennsylvania
- Thomas Jefferson University
- Clinical Trials Coordination Center
- University of Rochester Medical Center
- University of Miami
- Parkinson's Disease Research Education and Clinical Center
- The Parkinson's and Movement Disorder Institute
- Singapore General Hospital
- Department of Neurology
28
Link öffnet neuen Tab
Zitate (Scopus)